In 2004, a prospective cohort study demonstrated that OSA patients with coexisting CAD do not have nocturnal episodes of myocyte necrosis evidenced by detectable serum cTnT.25 This evidence concerns the gene TNNT2 and obstructive sleep apnea syndrome.